España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Aquestive Therapeutics
AQST
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Aquestive Therapeutics (AQST) Forecast
News
Earnings
Aquestive Therapeutics (AQST) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Aquestive Therapeutics (NASDAQ:AQST) Stock
Aquestive Therapeutics Stock (NASDAQ: AQST)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 17, 2024
Aquestive Therapeutics shares are trading hig...
Benzinga Newsdesk
Developer Of EpiPen Alternative Aquestive Stock Undervalued Despite Strong Clinical Data, Analyst Sees Huge Upside
Vandana Singh
Cantor Fitzgerald Initiates Coverage On Aques...
Benzinga Newsdesk
Monday, December 02, 2024
Aquestive Therapeutics Announces DA Feedback ...
Benzinga Newsdesk
Monday, November 11, 2024
HC Wainwright & Co. Reiterates Buy on Aquesti...
Benzinga Newsdesk
Wednesday, November 06, 2024
HC Wainwright & Co. Reiterates Buy on Aquesti...
Benzinga Newsdesk
Monday, November 04, 2024
Aquestive Therapeutics Q3 EPS $(0.13), Inline...
Benzinga Newsdesk
Aquestive Therapeutics Affirms FY2024 Sales G...
Benzinga Newsdesk
Friday, October 25, 2024
Leerink Partners Maintains Outperform on Aque...
Benzinga Newsdesk
Aquestive Therapeutics To Present Analysis Of...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Aquesti...
Benzinga Newsdesk
Thursday, October 24, 2024
Aquestive Therapeutics Announces Its Complete...
Benzinga Newsdesk
Tuesday, October 08, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Monday, September 30, 2024
Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate
Vandana Singh
Aquestive Therapeutics shares are trading hig...
Benzinga Newsdesk
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Leerink Partners Reiterates Outperform on Aqu...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Aquestiv...
Benzinga Newsdesk
Friday, September 27, 2024
Aquestive Therapeutics Announces Completion O...
Benzinga Newsdesk
Wednesday, August 14, 2024
Aquestive Therapeutics Reiterates Expected Ti...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Aquesti...
Benzinga Newsdesk
Monday, August 12, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Wednesday, August 07, 2024
Aquestive Therapeutics shares are trading hig...
Benzinga Newsdesk
Tuesday, August 06, 2024
Aquestive Therapeutics Sees FY24 Revenue $57M...
Benzinga Newsdesk
Aquestive Therapeutics Q2 2024 GAAP EPS $(0.0...
Benzinga Newsdesk
Friday, July 26, 2024
Aquestive Therapeutics shares are trading hig...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Aquesti...
Benzinga Newsdesk
Thursday, July 25, 2024
Aquestive Therapeutics Releases Topline PK Da...
Benzinga Newsdesk
Wednesday, June 26, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Tuesday, June 25, 2024
Oral Allergy Medication For Emergencies - Aquestive Therapeutics' Investigational Therapy Works Even With Exposure To Liquids Of Different Temperatures, Data Shows
Vandana Singh
Aquestive Therapeutics Reports Topline Data F...
Benzinga Newsdesk
Tuesday, June 18, 2024
Aquestive Therapeutics To Join Russell 3000 A...
Benzinga Newsdesk
Wednesday, June 05, 2024
HC Wainwright & Co. Reiterates Buy on Aquesti...
Benzinga Newsdesk
Monday, June 03, 2024
Aquestive Therapeutics Appoints Cassie Jung A...
Benzinga Newsdesk
Tuesday, May 28, 2024
Aquestive Therapeutics Announces Two Encore P...
Benzinga Newsdesk
Friday, May 10, 2024
Leerink Partners Initiates Coverage On Aquest...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Reiterates Buy on Aquesti...
Benzinga Newsdesk
Wednesday, May 08, 2024
Aquestive Therapeutics shares are trading low...
Benzinga Newsdesk
Tuesday, May 07, 2024
Aquestive Therapeutics Continues To Expect FY...
Benzinga Newsdesk
Aquestive Therapeutics Q1 2024 GAAP EPS $(0.1...
Benzinga Newsdesk
Tuesday, April 30, 2024
HC Wainwright & Co. Reiterates Buy on Aquesti...
Benzinga Newsdesk
Monday, April 29, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Aquestive Therapeutics Receives FDA Approval ...
Benzinga Newsdesk
Thursday, April 18, 2024
Ally Financial Reports Upbeat Earnings, Joins Badger Meter, Genuine Parts And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Friday, April 12, 2024
Aquestive Therapeutics To Present Crossover S...
Benzinga Newsdesk
Thursday, April 11, 2024
Piper Sandler Initiates Coverage On Aquestive...
Benzinga Newsdesk
Friday, April 05, 2024
HC Wainwright & Co. Reiterates Buy on Aquesti...
Benzinga Newsdesk
Thursday, April 04, 2024
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Lamb Weston Reports Weak Earnings, Joins Paragon 28, Resources Connection And Other Big Stocks Moving Lower On Thursday
Avi Kapoor
Aquestive Therapeutics shares are trading low...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
